Table of Contents
A growing body of evidence reveals that biofilms – complex microbial communities – pose a important and often underestimated risk in healthcare settings,rendering conventional cleaning methods ineffective and contributing to the rise of drug-resistant infections. New research highlights the efficacy of chlorine dioxide solutions in combating both wet and dry biofilms, offering a potential breakthrough in infection prevention.
The Escalating Challenge of Biofilms in Healthcare
Biofilms are more than just a cleaning problem; they represent a critical patient safety issue.These structured communities of microorganisms, encased in a self-produced protective matrix, readily colonize surfaces throughout healthcare environments. Once established, they are notoriously difficult to eradicate. According to experts, biofilms act as a reservoir for multi-drug resistant organisms (MDROs), shielding them from antibiotics and accelerating the spread of resistance through horizontal gene transfer.
Bacteria within a biofilm exhibit a staggering 10 to 1000-fold increase in resistance to antibiotics compared to their free-floating, or planktonic, counterparts. Studies suggest that biofilms are implicated in up to 65% of all microbial infections and a concerning 80% of chronic infections. Their presence on medical equipment, environmental surfaces, and within water systems directly contributes to healthcare-associated infections (HAIs), jeopardizing patient well-being.
Understanding the Diversity of Biofilms: Wet vs. Dry
while all biofilms share the common characteristic of a protective microbial community, their composition and resilience vary considerably. Biofilms can consist of bacteria, yeasts, fungi, and even viruses, often comprising multiple species. A key distinction lies between wet biofilms and dry biofilms.
Wet biofilms thrive in moist environments, such as within medical device channels, water lines, and on surfaces like sinks and showers. These biofilms are characterized by a slimy layer of extracellular polymeric substance (EPS), composed of polysaccharides, proteins, a
References
-
Ledwoch, K., Dancer, S.J., Otter, J.A., Kerr, K., Roposte, D., Rushton, L., Weiser, R., Mahenthiralingam, E., Muir, D.D. and Maillard, J.-Y. . (2018). Beware biofilm! Dry biofilms containing bacterial pathogens on multiple healthcare surfaces; a multi-center study. Journal of Hospital Infection, 100(3), pp.e47-e56. https://doi.org/10.1016/j.jhin.2018.06.028.
-
Maillard,J.-Y. and Centeleghe,I. (2023). How biofilm changes our understanding of cleaning and disinfection. Antimicrobial Resistance and Infection Control, [online] 12(1), p.95. https://doi.org/10.1186/s13756-023-01290-4.
-
K ledwoch, Vickery, K. and Maillard, J-Y. (2022). Dry surface biofilms: what you need to know. British journal of hospital medicine, 83(8), pp.1-3. https://doi.org/10.12968/hmed.2022.0274.
